MENU
+Compare
SXTC
Stock ticker: NASDAQ
AS OF
Jun 6, 04:59 PM (EDT)
Price
$2.10
Change
+$0.76 (+56.72%)
Capitalization
950.1K

SXTC China SXT Pharmaceuticals Inc. Forecast, Technical & Fundamental Analysis

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction... Show more

SXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SXTC with price predictions
Jun 05, 2025

SXTC in upward trend: price may ascend as a result of having broken its lower Bollinger Band on May 16, 2025

SXTC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 44 cases where SXTC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for SXTC just turned positive on June 05, 2025. Looking at past instances where SXTC's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SXTC advanced for three days, in of 186 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SXTC as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SXTC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.064) is normal, around the industry mean (62.463). P/E Ratio (0.034) is within average values for comparable stocks, (89.614). SXTC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.225) is also within normal values, averaging (19.198).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SXTC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SXTC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
SXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of traditional chinese medicines

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
No. 178 Taidong Road North
Phone
+86 52386298290
Employees
78
Web
http://www.sxtchina.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTCH31.490.45
+1.45%
Match Group
KE18.540.19
+1.04%
Kimball Electronics
WSBCP25.13-0.02
-0.08%
WesBanco
JBI8.00-0.11
-1.36%
Janus International Group
WRAP1.41-0.02
-1.40%
Wrap Technologies

SXTC and Stocks

Correlation & Price change

A.I.dvisor tells us that SXTC and SNDL have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTC and SNDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTC
1D Price
Change %
SXTC100%
+3.82%
SNDL - SXTC
28%
Poorly correlated
N/A
AYTU - SXTC
27%
Poorly correlated
-5.66%
CPHI - SXTC
24%
Poorly correlated
-8.05%
BHC - SXTC
23%
Poorly correlated
+1.09%
LNTH - SXTC
22%
Poorly correlated
+0.93%
More